LAZZARETTI, Mirca
 Distribuzione geografica
Continente #
NA - Nord America 3.663
AS - Asia 3.078
EU - Europa 2.670
SA - Sud America 435
AF - Africa 154
Continente sconosciuto - Info sul continente non disponibili 7
OC - Oceania 3
Totale 10.010
Nazione #
US - Stati Uniti d'America 3.554
SG - Singapore 1.198
CN - Cina 1.162
SE - Svezia 515
FI - Finlandia 508
IE - Irlanda 479
BR - Brasile 355
UA - Ucraina 316
DE - Germania 302
HK - Hong Kong 228
IT - Italia 192
VN - Vietnam 188
TR - Turchia 126
NL - Olanda 104
ZA - Sudafrica 95
CA - Canada 74
GB - Regno Unito 70
IN - India 50
FR - Francia 40
RU - Federazione Russa 39
AR - Argentina 35
CI - Costa d'Avorio 35
BD - Bangladesh 33
BE - Belgio 29
MX - Messico 19
PL - Polonia 17
EC - Ecuador 16
RO - Romania 15
JP - Giappone 13
IR - Iran 11
ES - Italia 10
LT - Lituania 10
IQ - Iraq 9
AT - Austria 8
CZ - Repubblica Ceca 8
KR - Corea 8
MA - Marocco 8
AE - Emirati Arabi Uniti 7
ID - Indonesia 7
PK - Pakistan 7
CL - Cile 6
EU - Europa 6
VE - Venezuela 6
CR - Costa Rica 4
EG - Egitto 4
JO - Giordania 4
MY - Malesia 4
PE - Perù 4
PY - Paraguay 4
TN - Tunisia 4
UY - Uruguay 4
CO - Colombia 3
DO - Repubblica Dominicana 3
HN - Honduras 3
KW - Kuwait 3
SA - Arabia Saudita 3
AU - Australia 2
BO - Bolivia 2
CH - Svizzera 2
CM - Camerun 2
HU - Ungheria 2
JM - Giamaica 2
KG - Kirghizistan 2
LB - Libano 2
LV - Lettonia 2
OM - Oman 2
SN - Senegal 2
UZ - Uzbekistan 2
AL - Albania 1
AO - Angola 1
BB - Barbados 1
BH - Bahrain 1
BN - Brunei Darussalam 1
CY - Cipro 1
DM - Dominica 1
EE - Estonia 1
GA - Gabon 1
GT - Guatemala 1
KE - Kenya 1
MN - Mongolia 1
NP - Nepal 1
NZ - Nuova Zelanda 1
PH - Filippine 1
PR - Porto Rico 1
PS - Palestinian Territory 1
SY - Repubblica araba siriana 1
TG - Togo 1
TW - Taiwan 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 10.010
Città #
Singapore 596
Dublin 478
Chandler 431
Ashburn 418
Jacksonville 343
Beijing 316
Santa Clara 292
Hong Kong 222
Ann Arbor 162
Dearborn 149
Dallas 137
Nanjing 128
Boardman 127
Izmir 100
San Mateo 92
Johannesburg 91
Princeton 89
Los Angeles 82
Parma 82
Ho Chi Minh City 81
New York 69
Shanghai 61
Wilmington 57
Toronto 55
Munich 53
Kunming 49
Jinan 44
Shenyang 43
Hebei 41
Hefei 39
São Paulo 39
Nanchang 38
Helsinki 36
Abidjan 35
Buffalo 33
Woodbridge 31
Brussels 29
Changsha 29
Düsseldorf 28
Moscow 27
Guangzhou 26
Tianjin 26
Des Moines 22
Pune 22
Zhengzhou 22
Hanoi 21
Jiaxing 20
Seattle 20
Chicago 19
Columbus 17
Bremen 16
Kocaeli 16
Warsaw 16
Marseille 14
Tokyo 13
Grafing 12
Hangzhou 12
Turku 12
Bologna 11
Boston 11
Houston 11
Leawood 11
London 11
Monmouth Junction 11
San Francisco 11
Stockholm 11
Amsterdam 10
Atlanta 10
Norwalk 10
Rio de Janeiro 10
Auburn Hills 9
Brooklyn 9
Mexico City 9
Nuremberg 9
Phoenix 9
Chongqing 8
Da Nang 8
Denver 8
Focsani 8
Fremont 8
Fuzhou 8
Ningbo 8
Orem 8
Ardabil 7
Mestre 7
Montreal 7
Redmond 7
Augusta 6
Belo Horizonte 6
Brno 6
Chennai 6
Guarulhos 6
Haikou 6
Haiphong 6
Lanzhou 6
Mumbai 6
Poplar 6
Porto Alegre 6
Quito 6
Seoul 6
Totale 5.921
Nome #
Angiopoietin-1 and Osteopontin Expression by CD138+ Myeloma Cells Rather Than VEGF and CD45 Correlates with Bone Marrow Angiogenesis in Multiple Myeloma Patients at the Diagnosis 178
The Histone Deacetylase Inhibitor Suberoylanilide Hydroxamic Acid (SAHA) Restores Cardiomyocyte Contractility in a Rat Model of Early Diabetes 173
HOXB7 expression by myeloma cells regulates their pro-angiogenic properties in multiple myeloma patients 163
Hypoxia and Hypoxia Inducible Factor (HIF)-1{alpha} in Multiple Myeloma: Effect on the Pro-Angiogenic Signature of Myeloma Cells and the Bone Marrow Microenvironment 161
Validation of a MGM1/OPA1 chimeric gene for functional analysis in yeast of mutations associated with dominant optic atrophy 151
HOXB7 is a key gene involved in Myeloma cell growth and Myeloma-induced angiogenesis in Multiple Myeloma patients 151
Effect of BP 2.94, a histamine H3-receptor agonist prodrug, on different models of colitis. 150
Chemokine receptors CXCR3 and CXCR4 expression in B cell and plasma cell malignancy 149
Hypoxia and hypoxia inducible factor (HIF)-1α in Multiple Myeloma patients: role in the angiogenic switch 147
Claustrum and insula in the human brain ageing. Cytologic and immunohistochemical findings 141
Oxygen tension in the bone marrow (BM) of patients with malignant and indolent monoclonal gammopathy: role of hypoxia and hypoxia-inducible factor (HIF)-1{alpha} in the regulation of gene expression and pro-angiogenic profiles of CD138+ cells 140
S. cerevisiae carrying a MGM1/OPA1 chimeric gene: a model for the study of dominant optic atrophy and for drug discovery 140
On p63, a p53 homologue, a new nuclear marker in human salivary glands 139
HOXB7 is critically involved in Multiple Myeloma-induced angiogenic switch 138
A translational perspective of the malignant hematopoietic proteoglycome 137
The homeobox gene HOXB7 regulates the production of pro-angiogenic molecole by myeloma cells and it is a target in myeloma-induced angiogenesis 137
Validation of a MGM1/OPA1 chimeric gene for functional analysis in yeast of mutations associated with dominant optic atrophy 137
Adult stem cells: perspectives for therapeutic applications. 136
Myeloma cells inhibit non-canonical wnt co-receptor ror2 expression in human bone marrow osteoprogenitor cells: effect of wnt5a/ror2 pathway activation on the osteogenic differentiation impairment induced by myeloma cells 136
Glial transporter EAAT2 and glutamatergic turnover in humna neocortex. An immunohistochemical study 132
Pro-angiogenetic properties of human myeloma cells: production of angiopoietin-1 and its potential relationship with myeloma-induced angiogenesis 132
A novel gene signature for molecular diagnosis of human prostate cancer by RT-qPCR. 131
CXCR3 and its binding chemokines in myeloma cells: expression of isoforms and potential relationships with myeloma cell proliferation and survival. 129
In vitro and In vivo evidences of osteocytes involvement in myeloma-induced osteolysis 129
Hematologic malignancies with extramedullary spread of disease. Case 1. Multiple myeloma with extramedullary involvement of the pleura and testes 128
"Identification of differential resistance/sensitivity cellular mechanisms triggered by Gentuzumab Ozogamicin in Acute Myeloid Leukemia 128
Angiopoietin-1 and osteopontin expression by CD138+myeloma cells rather than VEGF and CD45 correlates with bone marrow angiogenesis in Multiple Myeloma patients at the diagnosis. 127
On the human amygdaloid body in normal ageing. The aminoacidergic system 126
Human myeloma cells produce angiopoietin-1 but not angiopoietin-2: potential relationship with myeloma-induced angiogenesis 125
Expression of the glial glutamate transporter EAAT2 in normal ageing 124
Angiogenic switch in multiple myeloma patients 123
Ectopic production of osteopontin by human myeloma cells and its involvement in myeloma induced angiogenesis 122
The new tumor suppressor gene inhibitor of growth family member 4 (ING4) regulates the production of pro-angiogenic molecules by myeloma cells and suppresses hypoxia inducible factor (HIF)-1{alpha} activity being involved in myeloma-induced angiogenesis. 119
CC-Chemokine Ligand 20/Macrophage Inflammatory Protein-3A and CC-Chemokine Receptor 6 Are Overexpressed in Myeloma Microenvironment Related to Osteolytic Bone Lesions 117
Modulation of non canonical wnt5a/ror2 signaling pathway in human mesenchymal cells increases osteogenic differentiation counterbalancing the effect of myeloma cells 117
Morphological and functional alterations of the myenteric plexus in rats with TNBS-induced colitis 116
Increased osteocyte death in multiple myeloma patients: role in myeloma-induced osteoclast formation 116
Caratterizzazione strutturale ed identificazione dei fenotipi staminali della placenta umana 116
Genotoxicity Revaluation of Three Commercial Nitroheterocyclic Drugs: Nifurtimox, Benznidazole, and Metronidazole 116
Immunocytochemical expression of cytokeratins in human submandibular gland 115
Do human myeloma cells directly produce basic FGF? 115
Myeloma cells block RUNX2/CBFA1 activity in human bone marrow osteoblast progenitors and inhibit osteoblast formation and differentiation 114
On the myoepithelium of human salivary glands. An immunocytochemical study 114
The anti-myeloma effect of Lenalidomide is increased by hypoxia-inducible factor (HIF)-1a inhibition in multiple myeloma cells both in vitro and in vivo 113
Structural deciphering of the NG2/CSPG4 proteoglycan multifunctionality. 111
Production of Wnt inhibitors by myeloma cells: potential effects on canonical Wnt pathway in the bone microenvironment 110
Modeling human Coenzyme A synthase mutation in yeast reveals altered mitochondrial function, lipid content and iron metabolism 110
Macrophage inflammatory protein (MIP)-3 alpha/CCL20 and its receptor CCR6 are overexpressed in the bone microenvironment and involved in osteoclast formation in multiple myeloma patients. 110
Caratterizzazione strutturale ed identificazione dei fenotipi staminali della placenta umana 109
E-cigarettes induce toxicological effects that can raise the cancer risk 107
Human myeloma cells production of angiopoietin-1 and its potential relationship with myeloma-induced angiogenesis 106
Effetti del Growth Hormone sulla riparazione dell’infarto miocardico acuto. 102
Autophagy: A Player in response to Oxidative Stress and DNA Damage 102
p29ING4 regulates the production of pro-angiogenic molecules by human myeloma cells in normoxic and hypoxic conditions being involved in myeloma-induced angiogenesis. 102
Modulation of Transcription Profile Induced by Antiproliferative Thiosemicarbazone Metal Complexes in U937 Cancer Cells 101
Human myeloma cells production of angiopoietin-1 and its potential relationship with myeloma-induced angiogenesis 101
Human myeloma cells stimulate the receptor activator of nuclear factor-kappa B ligand (RANKL) in T lymphocytes: a potential role in multiple myeloma bone disease 101
Hypoxia-inducible factor (HIF)-1 is a therapeutic target in myeloma-induced angiogenesis and bone destruction in vitro and in vivo 100
Expression of pro-angiogenetic factofs by myeloma cells: role of the angiopoietin system 97
Searching for different sources of adult stem cells to repair the heart: the cardiogenic potential of human myocardial and bone marrow stromal cells 97
Proteasome Inhibitors Block Myeloma-Induced Osteocyte Death in Vitro and in Vivo in Multiple Myeloma Patients 96
Antiproliferative and chemopreventing activity of Citrullus colocynthis Schrad extracts 95
RANKL is critically involved in the physiopathology of multiple myeloma 95
Hypoxia-Inducible Factor (HIF)-1a Is A Therapeutic Target in Myeloma-Induced Angiogenesis and Bone Destruction in Vivo 93
The proteasome inhibitor bortezomib affects osteoblastogenesis and bone formation in vitro and in vivo in multiple myeloma patients. 92
Osteopontin and Angiopoietin Expression by Myeloma Cells Correlates with Bone Marrow Angiogenesis in Multiple Myeloma Patients. 91
Rigenerazione miocardica mediata da cellule staminali: potenziale endogeno e fonti extracardiache 90
P53, bcl-2 and Ki-67 expression in adenoid cystic carcinoma of the palate. A clinico-pathologic study of 21 cases with long-term follow-up 90
CD38 and bone marrow microenvironment 89
Studio del potenziale cardiogenico in vitro di monocolture e cocolture di cellule miocardiche e midollari 87
Molecular diagnosis of human prostate cancer (CaP) by RT-qPCR determination of gene expression signature 85
The proteasome inhibitor bortezomib affects osteoblast differentiation in vitro and in vivo in multiple myeloma patients 85
Myeloma cells induce imbalance in the osteoprotegerin/osteoprotegerin ligand system in the human bone marrow environment 84
Rigenerazione mediata da cellule staminali: potenziale endogeno e fonti extracardiache 82
The proteasome inhibitor bortezomib stimulates the osteogenic differentiation of mesenchymal cells in vitro and may increase osteoblast formation in vivo in multiple myeloma patients. 82
Hypoxia-inducible factor (HIF)-1α suppression in myeloma cells blocks tumoral growth in vivo inhibiting angiogenesis and bone destruction 82
Human Myeloma Cells Produce Angiopoietin-1 : Potential Relationship With Myeloma-Induced Angiogenesis 80
Morphological and functional alterations of the myenteric plexus in rats with TNBS-induced colitis. 79
Experimental development of a novel molecular tool for human prostate cancer (CaP) diagnosis by RT-qPCR determination of gene expression signature 79
Il potenziale rigenerativo miocardico di cellule umane di diversa origine 78
Intracranial hematopoiesis in a patient with AIDS-related central nervous system lymphoma and severe pancytopenia. 77
OPG/RANKL system imbalance in a case of hepatitis C-associated osteosclerosis: the pathogenetic key? 77
RANKL is critically involved in the physiopathology of multiple myeloma 77
Low bone marrow oxygen tension and hypoxia-inducible factor-1α overexpression characterize patients with multiple myeloma: role on the transcriptional and proangiogenic profiles of CD138(+) cells 76
Isolation and Characterization of Cardiogenic Cells from the Adult Hypertrophic Human Heart 74
Il Cuore, il Midollo Osseo e la Placenta come fonti di terapia cellulare per la rigenerazione cardiaca 74
Hypoxia-Inducible Factor (HIF)-1α Is a Therapeutic Target in Myeloma-Induced Angiogenesis 72
In vitro cardiogenic potential of human myocardial and marrow stromal cells. 71
Stem and basal cells in human salivary glands;P63,CK14 and BCL2 expressions 71
Human myeloma cells express the bone regulating gene Runx2/Cbfa1 and produce osteopontin that is involved in angiogenesis in multiple myeloma patients. 68
Unburned Tobacco Cigarette Smoke Alters Rat Ultrastructural Lung Airways and DNA 65
Glycoligands et glycocomplexes de Cu(II): activité antiproliférative, vectorisation et pénétration cellulaire 59
Totale 10.109
Categoria #
all - tutte 34.054
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 34.054


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021441 0 0 0 0 0 10 73 7 159 33 144 15
2021/2022449 9 5 5 43 13 17 52 64 23 44 42 132
2022/20231.720 207 208 117 108 139 179 34 100 559 13 43 13
2023/2024644 32 58 14 14 58 173 58 84 14 25 43 71
2024/20251.914 56 109 124 133 205 227 56 59 235 187 143 380
2025/20262.301 377 375 469 339 633 108 0 0 0 0 0 0
Totale 10.109